Cambridge Investment Research Advisors, Inc. Brainsway Ltd. Transaction History
Cambridge Investment Research Advisors, Inc.
- $36.4 Billion
- Q3 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Brainsway Ltd. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 21,471 shares of BWAY stock, worth $340,315. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,471Holding current value
$340,315% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BWAY
# of Institutions
47Shares Held
5.45MCall Options Held
26.8KPut Options Held
0-
Valor Management LLC Chicago, IL2.1MShares$33.3 Million47.3% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$15.9 Million0.55% of portfolio
-
Acadian Asset Management LLC Boston, MA395KShares$6.25 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny313KShares$4.96 Million0.01% of portfolio
-
Essex Investment Management CO LLC Boston, MA311KShares$4.92 Million0.82% of portfolio
About Brainsway Ltd.
- Ticker BWAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,519,200
- Market Cap $262M
- Description
- Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...